These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 6859885

  • 1. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ, Rigel DS, Kopf AW, Lieblich L, Lew R, Harris MN, Roses DF, Gumport SL, Ragaz A, Waldo E, Levine J, Levenstein M, Koenig R, Bart RS, Trau H.
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [Abstract] [Full Text] [Related]

  • 2. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
    Rokuhara S, Saida T, Oguchi M, Matsumoto K, Murase S, Oguchi S.
    J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cutaneous melanoma associated with previous nevus].
    Gutiérrez MP, Barengo M, Mainardi C, Garay I, Kurpis M, Ruiz Lascano A.
    Medicina (B Aires); 2009 May; 69(5):536-40. PubMed ID: 19897439
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of malignant melanoma.
    Rigel DS, Rogers GS, Friedman RJ.
    Dermatol Clin; 1985 Apr; 3(2):309-14. PubMed ID: 3830493
    [Abstract] [Full Text] [Related]

  • 10. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR, El-Zammar O.
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [Abstract] [Full Text] [Related]

  • 11. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP.
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [Abstract] [Full Text] [Related]

  • 12. Melanocytic nevi and malignant melanoma.
    Metcalf JS, Maize JC.
    Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA.
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [Abstract] [Full Text] [Related]

  • 18. Diagnosing and treating congenital melanocytic nevus simulating malignant melanoma.
    Kovach R, Hochberg J, Ardenghy M, Deangelis R, Welton W.
    W V Med J; 1996 Apr; 92(4):191-3. PubMed ID: 8772404
    [Abstract] [Full Text] [Related]

  • 19. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J, Cronin F, Duncan LM.
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [Abstract] [Full Text] [Related]

  • 20. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH, Kheir SM, Wolter JM, Coon JS.
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.